Ynvisible Interactive Inc. Granted Patent for Specialized Electrolyte and Electrochromic System
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2018) - Ynvisible Interactive Inc. (TSXV: YNV) (the "Company" or "ynvisible") a company that specializes in creating ultra-low power displays for printed electronics, announces today that it has been granted an EU patent (no. 2821458) for a specialized electrolyte formulation that allows for the integration of electrochromic inks directly into the electrolyte layers. This formulation offers a reduction in the overall number of ink layers required to produce electrochromic devices, substantially increasing manufacturing efficiency.
Typically, electrochromic displays have separate electrochromic and electrolyte layers which add to the complexity and cost of manufacture. ynvisible's patented invention offers an industry-leading solution that helps tackle performance and production efficiency issues and provides essential production efficiencies to brands that are looking to utilize electrochromic displays in their mainstream consumer goods. This patent now gives ynvisible control over a valuable functionality improvement that other companies using electrochromic inks may wish to license and use.
Our latest patent strengthens ynvisible's position as a leader in visual indicators for smart labels incorporating printed electronics. Specifically, this patent covers the proprietary formulation of ynvisible's irreversible displays, which have many applications in product status and quality indication, security, and authenticity. An irreversible display allows for a visual alarm to be permanently visible after a critical event has been recorded by the smart label system (e.g. a temperature threshold has been exceeded, or the item has been tampered with). Once activated, ynvisible's irreversible displays will remain visible even after a loss of structural integrity to the underlying circuits or power source. ynvisible is very pleased to add this patent to its growing portfolio of 18 patents - 8 granted, 10 pending.
"ynvisible is solving obstacles to the mass manufacture of electrochromic devices, and this invention is a critical element in this pursuit. Receiving an EU patent for recognizing this invention is an important milestone for us," says Dr. Carlos Pinheiro, CTO of ynvisible.
Beyond ynvisible's immediate interests to deploy this invention in its smart label and smart films solutions, this patent also has potential applications in other fields of electrochromics as well as in other electrochemical devices, such as advanced batteries and power sources where electrolytes play an important role.
Link to patent application:
Dr. Pinheiro will be covering this topic, along with ynvisible's other recent technical developments, at the 13th International Meeting of Electrochromism in Chiba, Japan Aug. 27-31, 2018 (http://ime-13.jp).
ynvisible is also pleased to announce it has granted a total of 375,000 stock options to consultants, employees and directors of the Company. The options will vest pursuant to the stock option agreements between ynvisible and each optionee and may be exercised at an exercise price of CAD$0.30 per common share, for a period of 5 years from the date of issuance or earlier in accordance with ynvisible's stock option plan.
About Ynvisible
ynvisible aims to be a leading company in the emerging printed electronics sector. Printed electronics uses new materials with electronic properties that are processable into inks and can be printed into thin layers (using conventional print house equipment) onto flexible materials, such as plastic and paper. ynvisible's proprietary electrochromic displays can be the face of every smart label. ynvisible's displays use almost no power. They are ultra-low weight, microscopically thin, flexible, yet robust. When combined with various sensors they bring functionality and life to smart products. Given the cost and power-consumption advantages over conventional electronics, printed electronics are a key enabler of mass adoption of the Internet of Things ("IoT"). Electrochromics-based smart labels offer simple non-obtrusive human interfaces to smart IoT objects. ynvisible's mix of services, materials and technology is a unique combination, which is winning favor among brand owners developing their IoT products for a huge market in its infancy. Since ynvisible's displays are printed, product designers can easily adapt electrochromics to the desired product design and required user experience.
For additional information, please contact the office at 604-788-2810.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
ON BEHALF OF THE BOARD OF DIRECTORS
"Jani-Mikael Kuusisto"
Chief Executive Officer
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements in this news release include, but are not limited to, statements regarding the business and operations of ynvisible, and information regarding the management, business and operations of ynvisible. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; delay or failure to receive board, shareholder or regulatory approvals; those additional risks set out in the Company's public documents filed on SEDAR at www.sedar.com; and other matters discussed in this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
News Provided by Newsfile Corp.
Sanofi: First patient outside U.S. treated in global Kevzara (sarilumab) clinical trial program for patients with severe COVID-19
